BC
Birchview Capital Portfolio holdings
AUM
$101M
1-Year Est. Return
34.62%
1 Year Est. Return
+34.62%
AUM
$115M
AUM Growth
-$7.74M
(-6.3%)
Holding
72
Top Buys
| 1 | +$728K | |
| 2 | +$493K | |
| 3 | +$476K | |
| 4 |
Xenon Pharmaceuticals
XENE
|
+$369K |
| 5 |
Prothena Corp
PRTA
|
+$351K |
Top Sells
| 1 | +$1.25M | |
| 2 | +$914K | |
| 3 | +$771K | |
| 4 |
Masimo
MASI
|
+$666K |
| 5 |
Axogen
AXGN
|
+$666K |
Sector Composition
| 1 | Healthcare | 96.33% |
| 2 | Energy | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$88.8B
| $41.8M | 36.29% |
685,192
+10
|
|
||
2
Corcept Therapeutics
CORT
$8.29B
| $7.54M | 6.55% |
66,000
-8,000
|
|
||
3
Acadia Pharmaceuticals
ACAD
$3.52B
| $4.38M | 3.8% |
263,400
-75,000
|
|
||
|
4
Prothena Corp
PRTA
$534M
| $4.12M | 3.58% |
332,974
+28,400
|
|
||
5
Biodesix
BDSX
$51.4M
| $3.59M | 3.11% |
5,736,113
|
|
||
6
Neurocrine Biosciences
NBIX
$13.9B
| $3.34M | 2.9% |
30,240
|
|
||
7
Elutia
ELUT
$37.8M
| $3M | 2.61% |
1,187,735
-37,754
|
|
||
|
8
Axogen
AXGN
$763M
| $2.98M | 2.59% |
161,000
-36,000
|
|
||
9
Phreesia
PHR
$1.34B
| $2.93M | 2.55% |
114,700
|
|
||
10
Travere Therapeutics
TVTX
$2.44B
| $2.47M | 2.15% |
138,000
-10,000
|
|
||
11
QuidelOrtho
QDEL
$1.91B
| $2.36M | 2.05% |
67,619
|
|
||
12
Protagonist Therapeutics
PTGX
$4.82B
| $2.32M | 2.02% |
48,002
+2
|
|
||
13
United Therapeutics
UTHR
$19.6B
| $2.31M | 2.01% |
7,500
-2,500
|
|
||
14
DocGo
DCGO
$113M
| $2.28M | 1.98% |
864,062
+100,000
|
|
||
15
Ovintiv
OVV
$9.25B
| $2.23M | 1.94% |
52,200
|
|
||
16
Harrow
HROW
$1.48B
| $1.94M | 1.68% |
72,910
|
|
||
|
17
Masimo
MASI
$7.97B
| $1.88M | 1.63% |
11,280
-4,000
|
|
||
18
EQT Corp
EQT
$33.7B
| $1.85M | 1.61% |
34,619
|
|
||
19
Castle Biosciences
CSTL
$642M
| $1.77M | 1.54% |
88,404
+10,404
|
|
||
20
Alkermes
ALKS
$5B
| $1.65M | 1.43% |
50,000
|
|
||
21
Stoke Therapeutics
STOK
$1.84B
| $1.4M | 1.21% |
210,005
+5
|
|
||
22
Treace Medical Concepts
TMCI
$407M
| $1.38M | 1.2% |
164,947
+3,597
|
|
||
23
Foghorn Therapeutics
FHTX
$226M
| $1.13M | 0.99% |
310,930
|
|
||
24
uniQure
QURE
$3.57B
| $940K | 0.82% |
88,697
+68,697
|
|
||
25
KalVista Pharmaceuticals
KALV
$561M
| $773K | 0.67% |
67,002
+2
|
|